De novo Neurosteroidogenesis in Human Microglia: Involvement of the 18 kDa Translocator Protein
Authors:
- Lorenzo GermelliLorenzo Germelli
- Eleonora Da PozzoEPEleonora Da Pozzo
- Chiara GiacomelliCGChiara Giacomelli
- Chiara TremolantiCTChiara Tremolanti
- Laura MarchettiLMLaura Marchetti
- Christian H. WetzelCWChristian H. Wetzel
- Elisabetta BarresiEBElisabetta Barresi
- Sabrina TalianiSTSabrina Taliani
- Federico Da SettimoFSFederico Da Settimo
- Claudia MartiniClaudia Martini
- Barbara CostaBCBarbara Costa
Open Access
- 18 March 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (6) , 3115
Abstract
Neuroactive steroids are potent modulators of microglial functions and are capable of counteracting their excessive reactivity. This action has mainly been ascribed to neuroactive steroids released from other sources, as microglia have been defined unable to produce neurosteroids de novo. Unexpectedly, immortalized murine microglia recently exhibited this de novo biosynthesis; herein, de novo neurosteroidogenesis was characterized in immortalized human microglia. The results demonstrated that C20 and HMC3 microglial cells constitutively express members of the neurosteroidogenesis multiprotein machinery—in particular, the transduceosome members StAR and TSPO, and the enzyme CYP11A1. Moreover, both cell lines produce pregnenolone and transcriptionally express the enzymes involved in neurosteroidogenesis. The high TSPO expression levels observed in microglia prompted us to assess its role in de novo neurosteroidogenesis. TSPO siRNA and TSPO synthetic ligand treatments were used to reduce and prompt TSPO function, respectively. The TSPO expression downregulation compromised the de novo neurosteroidogenesis and led to an increase in StAR expression, probably as a compensatory mechanism. The pharmacological TSPO stimulation the de novo neurosteroidogenesis improved in turn the neurosteroid-mediated release of Brain-Derived Neurotrophic Factor. In conclusion, these results demonstrated that de novo neurosteroidogenesis occurs in human microglia, unravelling a new mechanism potentially useful for future therapeutic purposes.Keywords
Funding Information
- Italian Ministry of Education, Universities and Research (2017MT3993)
This publication has 88 references indexed in Scilit:
- A TSPO ligand is protective in a mouse model of multiple sclerosisEMBO Molecular Medicine, 2013
- An ADIOL-ERβ-CtBP Transrepression Pathway Negatively Regulates Microglia-Mediated InflammationCell, 2011
- Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expressionFrontiers in Endocrinology, 2011
- Cholesterol transport in steroid biosynthesis: Role of protein–protein interactions and implications in disease statesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Progesterone reverses 17β‐estradiol‐mediated neuroprotection and BDNF induction in cultured hippocampal slicesEuropean Journal of Neuroscience, 2009
- Progesterone Influence on Neurite Outgrowth Involves MicrogliaEndocrinology, 2008
- Brain microglia express steroid-converting enzymes in the mouseThe Journal of Steroid Biochemistry and Molecular Biology, 2008
- Neurosteroids in the context of stress: Implications for depressive disordersPharmacology & Therapeutics, 2007
- Steroidogenic Acute Regulatory Protein Expression and Pregnenolone Synthesis in Rat Astrocyte CulturesJournal of Neuroendocrinology, 2007
- Synthesis and Evaluation of Heteroaryl-Substituted Dihydronaphthalenes and Indenes: Potent and Selective Inhibitors of Aldosterone Synthase (CYP11B2) for the Treatment of Congestive Heart Failure and Myocardial FibrosisJournal of Medicinal Chemistry, 2006